Silverstein RL - Search Results

1

Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice.

Febbraio M, Podrez EA, Smith JD, Hajjar DP, Hazen SL, Hoff HF, Sharma K, Silverstein RL. Febbraio M, et al. Among authors: silverstein rl. J Clin Invest. 2000 Apr;105(8):1049-56. doi: 10.1172/JCI9259. J Clin Invest. 2000. PMID: 10772649 Free PMC article.

2

A novel family of atherogenic oxidized phospholipids promotes macrophage foam cell formation via the scavenger receptor CD36 and is enriched in atherosclerotic lesions.

Podrez EA, Poliakov E, Shen Z, Zhang R, Deng Y, Sun M, Finton PJ, Shan L, Febbraio M, Hajjar DP, Silverstein RL, Hoff HF, Salomon RG, Hazen SL. Podrez EA, et al. Among authors: silverstein rl. J Biol Chem. 2002 Oct 11;277(41):38517-23. doi: 10.1074/jbc.M205924200. Epub 2002 Jul 26. J Biol Chem. 2002. PMID: 12145296 Free article.

3

CD36 modulates migration of mouse and human macrophages in response to oxidized LDL and may contribute to macrophage trapping in the arterial intima.

Park YM, Febbraio M, Silverstein RL. Park YM, et al. Among authors: silverstein rl. J Clin Invest. 2009 Jan;119(1):136-45. doi: 10.1172/JCI35535. Epub 2008 Dec 8. J Clin Invest. 2009. PMID: 19065049 Free PMC article.

4

Recombinant glutathione S-transferase/CD36 fusion proteins define an oxidized low density lipoprotein-binding domain.

Pearce SF, Roy P, Nicholson AC, Hajjar DP, Febbraio M, Silverstein RL. Pearce SF, et al. Among authors: silverstein rl. J Biol Chem. 1998 Dec 25;273(52):34875-81. doi: 10.1074/jbc.273.52.34875. J Biol Chem. 1998. PMID: 9857015 Free article.

5

A null mutation in murine CD36 reveals an important role in fatty acid and lipoprotein metabolism.

Febbraio M, Abumrad NA, Hajjar DP, Sharma K, Cheng W, Pearce SF, Silverstein RL. Febbraio M, et al. Among authors: silverstein rl. J Biol Chem. 1999 Jul 2;274(27):19055-62. doi: 10.1074/jbc.274.27.19055. J Biol Chem. 1999. PMID: 10383407 Free article.

6

Macrophage scavenger receptor CD36 is the major receptor for LDL modified by monocyte-generated reactive nitrogen species.

Podrez EA, Febbraio M, Sheibani N, Schmitt D, Silverstein RL, Hajjar DP, Cohen PA, Frazier WA, Hoff HF, Hazen SL. Podrez EA, et al. Among authors: silverstein rl. J Clin Invest. 2000 Apr;105(8):1095-108. doi: 10.1172/JCI8574. J Clin Invest. 2000. PMID: 10772654 Free PMC article.

7

CD36 in atherosclerosis. The role of a class B macrophage scavenger receptor.

Nicholson AC, Febbraio M, Han J, Silverstein RL, Hajjar DP. Nicholson AC, et al. Among authors: silverstein rl. Ann N Y Acad Sci. 2000 May;902:128-31; discussion 131-3. Ann N Y Acad Sci. 2000. PMID: 10865832 Review.

8

CD36 and atherosclerosis.

Silverstein RL, Febbraio M. Silverstein RL, et al. Curr Opin Lipidol. 2000 Oct;11(5):483-91. doi: 10.1097/00041433-200010000-00006. Curr Opin Lipidol. 2000. PMID: 11048891 Review.

9

CD36: a class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolism.

Febbraio M, Hajjar DP, Silverstein RL. Febbraio M, et al. Among authors: silverstein rl. J Clin Invest. 2001 Sep;108(6):785-91. doi: 10.1172/JCI14006. J Clin Invest. 2001. PMID: 11560944 Free PMC article. Review. No abstract available.

10

Scavenger receptors class A-I/II and CD36 are the principal receptors responsible for the uptake of modified low density lipoprotein leading to lipid loading in macrophages.

Kunjathoor VV, Febbraio M, Podrez EA, Moore KJ, Andersson L, Koehn S, Rhee JS, Silverstein R, Hoff HF, Freeman MW. Kunjathoor VV, et al. J Biol Chem. 2002 Dec 20;277(51):49982-8. doi: 10.1074/jbc.M209649200. Epub 2002 Oct 9. J Biol Chem. 2002. PMID: 12376530 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

208 results

Search Page